Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 11/20 | 0.72 |
| ▸ | SLC40A1 | Q9NP59 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KIT | P10721 | 1/20 | 0.44 |
| ▸ | CKS1B | P61024 | 1/20 | 0.43 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.43 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10318149 | 0.95 | AXL (0.66) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10319009 | 0.94 | AXL (0.64) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10317905 | 0.92 | AXL (0.73) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10317649 | 0.92 | AXL (0.63) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10316964 | 0.91 | AXL (0.62) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10317890 | 0.91 | AXL (0.61) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10317632 | 0.91 | AXL (0.59) | AXLSLC40A1MEN1AGTR1KMT2A | |
| SCHEMBL10317039 | 0.90 | AXL (0.63) | AXLMEN1AGTR1KMT2AKIT | |
| SCHEMBL10317016 | 0.90 | AXL (0.58) | AXLMEN1AGTR1KMT2AKIT | |
| SCHEMBL10317750 | 0.90 | AXL (0.58) | AXLSLC40A1MEN1AGTR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2262772-B1 | QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS | MAX PLANCK GESELLSCHAFT (DE) | 2012-07-18 | — | — | EP | claimed |